A proposed federal rule says that patients must be informed after mammograms if they have dense breasts.
by Carly Weeks
Survivors and advocates display their posters alongside the work of thousands of cancer researchers.
by Kevin McLaughlin
Drug developers behind the six currently approved checkpoint inhibitors discuss the pros and cons of competition in the field.
by Kate Yandell
Cancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research.
FORWARD LOOK
Payments can be put off during treatment and for six months after.
by Bradley Jones
POLICY MATTERS
HPV vaccination and screening can help eradicate cervical cancer and other malignancies.
by Anna R. Giuliano, PhD
Precision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options.
by Kendall K. Morgan
Patient-reported outcomes may help shape the future of cancer care.
by Stephen Ornes
Get Involved
Children affected by a parent’s cancer get a unique summer camp experience at Camp Kesem.
by Hanna Greeman
A new survey suggests that young adults with colorectal cancer struggle to receive an accurate, prompt diagnosis.
Clinical health psychologist Jamie Ostroff discusses how feelings of blame surrounding a lung cancer diagnosis affect physical and mental health.
by Jen Tota McGivney
Drugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer.
A pair of studies demonstrated encouraging clinical outcomes with two different CAR T-cell therapies for patients with advanced solid tumors.
The U.S. Food and Drug Administration has for the first time approved an immunotherapeutic for breast cancer.
Researchers are studying how to treat EGFR-positive non-small cell lung cancer that has become resistant to tyrosine kinase inhibitors.
A Lesson in Service
donate to the AACR